BioCurex Inc. Announces Filing of New Patent for Cancer Diagnostics, Therapeutics Based on Its Proprietary RECAF(TM) Technology

November 4, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

RICHMOND, British Columbia, Nov. 3, 2010 (GLOBE NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) -- today announced that it has filed a new patent within the Patent Cooperation Treaty, which presently includes 142 countries.

Twitter
LinkedIn
Facebook
Email
Print